ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2032

Genome-Wide Association Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci

Laura A McIntosh1, Miranda C Marion2, Marc Sudman1, Mary E Comeau2, Sampath Prahalad3, John F. Bohnsack4, Johannes P Haas5, Carol A Wallace6, Daniel J Lovell7, Thomas A Griffin8, Mara L Becker9, Peter A Nigrovic10,11, Marilynn Punaro12, Carlos D Rosé13, Carol A Wise14, Halima Moncrieffe15, Timothy D Howard16, Carl D Langefeld17, Susan D Thompson15,18 and Boston Children’s JIA Registry, JIA gene expression studies, NIAMS JIA genetic registry, TREAT study, Understanding TNF Therapy in JIA Project, 1Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Biostatistical Sciences and Center for Public Health Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, 3Pediatrics, Emory Children's Center, Atlanta, GA, 4Division of Allergy, Immunology and Pediatric Rheumatology, University of Utah, Salt Lake City, UT, 5German Centre for Rheumatology in Children and Young People, Garmisch-Partenkirchen, Germany, 6Pediatrics, Seattle Children's Hospital, Seattle, WA, 7Rheumatology, PRCSG Cincinnati Children's Hospital Medical Center, Cinncinnati, OH, 8Levine Children’s Hospital at Carolinas Medical Center, Charlotte, NC, 9Rheumatology, Children's Mercy Kansas City, Kansas City, MO, 10Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Boston, MA, 11Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 12Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX, 13Pediatrics, Division of Rheumatology, Nemours/A.I. duPont Hospital for Children, Thomas Jefferson University, Wilmington, DE, 14Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, TX, 15Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 16Center for Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC, 17Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, 18Center for Autoimmune Disease Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: genetics, Genomics and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Genetics, Genomics and Proteomics I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease, affecting approximately 1 in 1,000 children. JIA is a complex genetic trait and encompasses a wide spectrum of clinical heterogeneity. To date, genetic association studies in JIA had limited sample sizes, used heterogeneous patient populations containing all disease subtypes, or included only candidate regions (e.g. Immunochip). In this study, we focused on oligoarticular and rheumatoid factor negative (RF–) polyarticular subtypes of JIA because they are clinically similar and the most prevalent forms of disease. This study employed large cohorts and imputed SNP data in a genome-wide association study (GWAS) to catalog novel genetic risk factors.

Methods: Three cohorts totaling 2,751 oligoarticular or RF– polyarticular JIA cases and 15,864 controls, all of European ancestry, were genotyped using two platforms. Cohort 1 (814 cases and 3,055 controls) and cohort 2 (1,057 cases and 11,824 controls) were genotyped on the Affymetrix Genome-Wide Human SNP 6.0 Array, while cohort 3 (880 cases and 985 controls) was genotyped on the Illumina HumanCoreExome-12+ Array. Imputation was performed using 1000 Genomes Project data, followed by a meta-analysis of all 3 cohorts.

Results: Meta-analysis resulted in suggestive evidence of association (P<1×10-6) at 10 regions along the genome: JAK1 (rs10889504: OR=0.78, P=4.18×10-7), PRR9_LOR (rs873234: OR=1.43, P=5.12×10-8), PTH1R (rs1138518: OR=1.23, P=1.87×10-7), ILDR1_CD86 (rs1138518: OR=1.45, P=6.73×10-8), FLJ41649 (rs10807228: OR=1.42, P=5.80×10-7), AHI1_LINC00271 (rs9321502: OR=1.18, P=3.48×10-7), HBP1 (rs111865019: OR=0.84, P=7.29×10-7), ASAP1 (rs34962169: OR=1.43, P=6.36×10-7), WDFY4 (rs1904603: OR=1.27, P=1.79×10-7), and RNF215 (rs5753109: OR=1.19, P=3.09×10-7). Among these regions, association studies in other autoimmune diseases provided additional evidence of support for JAK1 (Celiac Disease: rs12409333 – r2=0.898, P=3.80×10-5, Multiple Sclerosis: rs12409333 – r2=0.898, P=2.70×10-4), ILDR1_CD86 (Celiac Disease: rs2061197 – r2=0.407, P=8.55×10-6), AHI1_LINC00271 (Autoimmune Thyroid Disease: rs2179781 – r2=0.757, P=4.84×10-4, Celiac Disease: rs12206850 – r2=0.701, P=6.89×10-4, Multiple Sclerosis: rs11154801 – r2=0.740, P=1.00×10-13, Type 1 Diabetes: rs11154801 -r2=0.740, P=2.55×10-5) and WDFY4 (Systemic Lupus Erythematosus: rs877819 – r2=0.473, P=8.00×10-9). Furthermore, cis expression quantitative trait loci were shown for PTH1R (rs2242116), AHI1 (rs2614276), HBP1 (rs7790080, rs2301801, and rs2237659), WDFY4 (rs2940707), and RNF215 (rs2242116). Histone modifications of JAK1 (rs6588107: H3K4Me1, H3K27Ac and rs72922282: H3K4Me3, H3K27Ac), AHI_LINC00271 (rs6935146: H3K4Me1), and ASAP1 (rs67434056: H3K4Me1) showed additional regulation of gene expression.

Conclusion: These genome-wide genetic association results are supported by findings in other autoimmune diseases and/or relate to gene expression levels. Thus, they are likely to represent novel regions potentially contributing to the disease pathology of oligoarticular and RF– polyarticular JIA.


Disclosure: L. A. McIntosh, None; M. C. Marion, None; M. Sudman, None; M. E. Comeau, None; S. Prahalad, None; J. F. Bohnsack, None; J. P. Haas, None; C. A. Wallace, None; D. J. Lovell, None; T. A. Griffin, None; M. L. Becker, None; P. A. Nigrovic, None; M. Punaro, None; C. D. Rosé, None; C. A. Wise, None; H. Moncrieffe, None; T. D. Howard, None; C. D. Langefeld, None; S. D. Thompson, None.

To cite this abstract in AMA style:

McIntosh LA, Marion MC, Sudman M, Comeau ME, Prahalad S, Bohnsack JF, Haas JP, Wallace CA, Lovell DJ, Griffin TA, Becker ML, Nigrovic PA, Punaro M, Rosé CD, Wise CA, Moncrieffe H, Howard TD, Langefeld CD, Thompson SD. Genome-Wide Association Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/genome-wide-association-analysis-reveals-novel-juvenile-idiopathic-arthritis-susceptibility-loci/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-association-analysis-reveals-novel-juvenile-idiopathic-arthritis-susceptibility-loci/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology